4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-20-018703
Director sold 20,000 shares at an average $82.39 ($1,647,730)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2020-07-06 | Sale | −14,689 | $82.16 | $1,206,920 | 559,501 | I |
| Bolzon Bradley J PhD Director | 2020-07-06 | Sale | −5,311 | $83.00 | $440,810 | 554,190 | I |
| Open-market sales · 20,000 sh · avg $82.39 · $1,647,730 | |||||||
Loading xslF345X03/doc4.xml…